Valuation: B.R.A.I.N. Biotechnology Research and Information Network AG

Market Cap 63.14M 71.06M 58.93M 53.71M 101M 6.83B 102M 713M 276M 3.49B 267M 261M 11.21B P/E 2026 *
-8.45x
P/E 2027 * -19x
Enterprise Value 85.43M 96.16M 79.74M 72.68M 137M 9.24B 138M 965M 374M 4.73B 361M 353M 15.17B EV / Sales 2026 *
1.64x
EV / Sales 2027 * 1.43x
Free-Float
41.6%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: B.R.A.I.N. Biotechnology Research and Information Network AG

Manager TitleAgeSince
Director of Finance/CFO 56 01/10/2022
Chief Tech/Sci/R&D Officer 40 01/01/2023
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 54 09/03/2017
Chairman 65 08/03/2023
Director/Board Member 61 14/10/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 71.06M
+1.26%-1.15%-6.97%+34.01% 81.72B
+1.58%-1.20%-6.51%+47.06% 64.17B
+2.10%-1.12%-11.81%+15.55% 38.77B
+0.08%-2.53%-11.63%+22.88% 23.08B
+1.92%+1.75%+39.49%+96.28% 16.81B
+3.98%+0.18%-8.01%+40.64% 15.15B
+3.00%-0.48% - - 12.56B
+1.01%+1.42%+7.31%+49.32% 10.28B
-1.78%-2.33%-1.84%+9.05% 8.48B
Average +1.32%-0.85%+0.00%+39.35% 30.11B
Weighted average by Cap. +1.52%-1.56%-4.30%+37.72%

Financials

2026 *2027 *
Net sales 52.13M 58.68M 48.66M 44.35M 83.64M 5.64B 84.42M 589M 228M 2.88B 220M 216M 9.25B 62.76M 70.64M 58.58M 53.39M 101M 6.79B 102M 709M 275M 3.47B 265M 259M 11.14B
Net income -7.43M -8.36M -6.94M -6.32M -11.92M -804M -12.03M -83.93M -32.52M -411M -31.4M -30.72M -1.32B -3.36M -3.78M -3.14M -2.86M -5.39M -363M -5.44M -37.94M -14.7M -186M -14.2M -13.89M -596M
Net Debt 22.3M 25.09M 20.81M 18.97M 35.77M 2.41B 36.1M 252M 97.58M 1.23B 94.21M 92.17M 3.96B 26.4M 29.72M 24.64M 22.46M 42.36M 2.86B 42.76M 298M 116M 1.46B 112M 109M 4.69B
Logo B.R.A.I.N. Biotechnology Research and Information Network AG
BRAIN Biotech AG, is formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG, is a Germany -based Company. The Company is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Employees
280
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-